ZURICH/BERLIN, Feb 2 (Reuters) - The Swiss blue-chip SMI was seen opening up 0.45% at 11,251 points on Thursday,
according to premarket indications by bank Julius Baer .
Here are some of the main factors that may affect Swiss
stocks on Thursday:
ROCHE HOLDING AG Roche ROG.S predicted a decline in 2023 earnings as revenue
growth from new drugs such as haemophilia treatment Hemlibra and
multiple sclerosis drug Ocrevus would not make up for a drop in
demand for COVID-19 treatments and diagnostic testing.
ABB LTD ABB reported better than expected earnings for its fourth
quarter on Thursday, posting net profit of $1.13 billion as the
Swiss engineering and group said it expected strong revenue
growth at the start of 2023.
JULIUS BAER Julius Baer said net profit fell 12% in 2022 in a tough
market environment, as the Swiss bank said it closed its 2020-22
business cycle by hitting all its financial targets.
SWISS RE Swiss Re announced a reorganisation on Thursday that will
split its reinsurance business into two parts that will operate
with greater independence, which it said would improve
efficiency.
COMPANY NEWS
*Teresa Graham appointed Roche Pharmaceuticals CEO from
March
*Credit Suisse weighs splitting China team in first Boston
revamp - Bloomberg News -
*Swatch Group announces dividend proposal
*Hiag Immobilien Holding says appoints Stefan Hilber as CFO
*Mobilezone Holding AG CEO Markus Bernhard will resign on 30
June 2024 as Mobilezone Group CEO
ANALYSTS' VIEWS
UBS Group - Jefferies raises target price to 24 sfr
from 23
ECONOMY
Swiss Q1 consumer confidence due at 0800 GMT.
(Reporting by Zurich newsroom and Berlin Speed Desk)
Daily Swiss stock market report in German All SMI constituent stocks DJ STOXX index Top 10 STOXX sectors Top 10 EUROSTOXX sectors Swiss mid-cap index Swiss all-share index Swiss market digest Sector overview All Swiss news Swiss research news All equity news SPEED GUIDES: ))
